Drugs / Bupivocaine
last change Dec 2016 re-read 3 minutes ago

Bupivocaine

Developed for
gallstones
Investigated by
University Hospitals Coventry and Warwickshire NHS Trust

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase not applicable1 trial
— NCT01090882 Jul → Oct 2009 gallstones University Hospitals Coventry and Warwickshire NHS Trust Completed No outcome recorded
Comparator or background therapy2 trials
Phase 3 NCT02444260 Comparator Dec 2013 → Dec 2015 — The University of The West Indies Unknown No outcome recorded
Phase 4 NCT00542139 Comparator Dec 2007 → Nov 2008 osteoarthritis Hadassah Medical Organization Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Bupivocaine ClinicalTrials.gov intervention name — accepted as the source's own label NCT01090882 ↗
2

NCT00542139 ↗

NCT02444260 ↗

Route Other “Intraarticular injection of 10ml of Bupivocaine” NCT00542139 ↗